{"entity":{"id":"nct01394679","kind":"trial","name":"A Phase 3 Study of 99mTC-EC-DG SPECT/CT Versus PET/CT in Lung Cancer","aka":[],"tldr":"A phase 3 trial in lung cancer, run by Cell>Point LLC, not yet recruiting.","summary":"A Phase 3 Study of 99mTC-EC-DG SPECT/CT Versus PET/CT in Lung Cancer is a phase 3, interventional study registered as NCT01394679 by Cell>Point LLC, with a registry enrolment figure of 154 participants, started 2025-05-01 and due to reach its primary completion in 2025-12. Interventions recorded: (99m Tc) ECDG (Ethylenedicysteine-Deoxyglucose); 18 F FDG followed by PET/CT imaging. Conditions listed: Lung Cancer. Primary outcome: Efficacy:Comparison of 99mTc-EcC-DG SPECT/CT images to 18F-FDG PET/CT images of primary lung cancer lesion and metastatic lesions. Lung eligibility wording from the registry: \"The patient has had a non incisional biopsy demonstrating definitive evidence for lung cancer OR have clinical evidence and CT scan results consistent with a diagnosis of lung cancer\". Sites: United States. No results are recorded here; the registry entry is the source.","status":"planned","asOf":"2026-09-25","links":[{"label":"ClinicalTrials.gov NCT01394679","url":"https://clinicaltrials.gov/study/NCT01394679"}],"tags":["ctgov-ingest","lung-deep-dive"],"related":[],"cancers":["lung-cancer"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT01394679","phase":"3","setting":"A Multicenter Phase 3 Study Comparing the Diagnostic Accuracy of 99mTc EC DG SPECT/CT Versus 18F FDG PET/CT for Diagnosing and Staging Patients Who Have Clinical and Radiological (CT) Evidence Consistent With a Diagnosis of Lung Cancer","sponsor":"Cell>Point LLC","participation":[{"nct":"NCT01394679","source":"https://clinicaltrials.gov/study/NCT01394679","fetchedAt":"2026-10-07T16:52:26.734Z","studySha256":"66ca99e47ad2fe04040299c7789ccb7910a1f624835d9dca780c4cadad8bfcbf","overallStatus":"NOT_YET_RECRUITING","lastUpdatePosted":"2025-04-03","leadSponsor":"Cell>Point LLC","collaboratorCount":0,"minimumAge":"18 Years","sex":"ALL","healthyVolunteers":false,"hasEligibility":true,"enrolment":154,"enrolmentType":"ESTIMATED","siteCount":1,"recruitingSiteCount":0,"countries":["United States"]}],"started":"2025-05-01","startedType":"estimated","enrolled":154,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct01394679/","neighbours":{"cancer":[{"id":"lung-cancer","kind":"cancer","name":"Lung cancer (all types)","route":"/cancers/lung-cancer/"}],"term":[{"id":"lung-trials-open-today","kind":"term","name":"Lung cancer trials open today (registry snapshot)","route":"/terms/lung-trials-open-today/"}]}}